Brief: Context Therapeutics Announces Positive Data From ONA-XR in Early Breast Cancer At 2021 San Antonio Breast Cancer Symposium
09/12/2021 23:03
Dec 9 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS® ANNOUNCES POSITIVE DATA FROM ONA-XR
IN
EARLY BREAST CANCER AT 2021 SAN ANTONIO BREAST CANCER SYMPOSIUM
Source text for Eikon: ID:nGNX2d16hG
Further company coverage: CNTX.O
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202